L

Livia Stanger

University of Michigan

ORCID: 0000-0001-6034-0646

Publishes on Antiplatelet Therapy and Cardiovascular Diseases, Eicosanoids and Hypertension Pharmacology, Platelet Disorders and Treatments. 31 papers and 176 citations.

PubIndex Score79Top 21% · early-careerHow it's scored

31Publications

176Total Citations

First publication: 2020First senior author: 2023

Antiplatelet Therapy and Cardiovascular Diseases Eicosanoids and Hypertension Pharmacology Platelet Disorders and Treatments Venous Thromboembolism Diagnosis and Management Inflammatory mediators and NSAID effects

Top publicationsby citations

Antiplatelet strategies: past, present, and future

Livia Stanger, Michael Holinstat, Adriana Yamaguchi|Journal of Thrombosis and Haemostasis|2023

Cited by 39

DHA 12‐LOX‐derived oxylipins regulate platelet activation and thrombus formation through a PKA‐dependent signaling pathway

Adriana Yamaguchi, Michael Holinstat, Melissa Standley et al.|Journal of Thrombosis and Haemostasis|2020

Cited by 36

Bioactive lipid regulation of platelet function, hemostasis, and thrombosis

Livia Stanger, Michael Holinstat|Pharmacology & Therapeutics|2023

Cited by 31

The oxylipin analog CS585 prevents platelet activation and thrombosis through activation of the prostacyclin receptor

Livia Stanger, Michael Holinstat, Andrew D. White et al.|Blood|2023

Cited by 18

Experimental venous thrombus resolution is driven by IL-6 mediated monocyte actions

Peter K. Henke, Sriganesh Sharma, Megan Elfline et al.|Scientific Reports|2023

Cited by 17